tirzepatide weight loss efficacy Body with in SURPASS 1‐5.56,73‐76,87 Data are Incretin-based therapies for the treatment
Description
It gives your body time to adjust to the dual GIP and GLP-1 receptor activation that makes tirzepatide unique
Our qualified clinicians assess each consultation individually to make sure the treatment is right for you and won't interact with any other medications or conditions you have
I take 12.5 weekly
This ensures that their tirzepatide is an exact molecular replica of the base formula
General Disclaimer: Brello Health is not intended to diagnose, treat, or cure any disease
In head-to-head trials like SURMOUNT-5, tirzepatide has demonstrated greater weight loss compared to single GLP-1 receptor agonists like semaglutide
